Early Identification and Eculizumab Treatment of Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report

妊娠相关非典型溶血性尿毒综合征的早期识别和依库珠单抗治疗:病例报告

阅读:1

Abstract

Pregnancy-associated atypical hemolytic-uremic syndrome (p-aHUS) is a rare thrombotic microangiopathy that leads to increased fetal and maternal morbidity and mortality. Early identification and timely treatment can save lives and improve prognosis. p-aHUS should be highly suspected in patients presenting with microangiopathic hemolytic anemia, thrombocytopenia, and acute progressive renal failure in late pregnancy or postpartum. This case report describes a 26-year-old healthy pregnant woman who underwent an emergency cesarean section at 38 weeks of gestation due to severe preeclampsia and placental abruption. Postoperatively, she rapidly developed persistent hypertension, hemolysis, elevated liver enzymes, and thrombocytopenia, which were initially considered to indicate HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelets) syndrome. However, the patient developed acute renal failure postoperatively, and her condition progressively worsened. After the diagnosis of p-aHUS was finally confirmed, the patient received plasma exchange and eculizumab treatment, resulting in significant clinical improvement.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。